Condition (MeSH)
Glycogen Storage Disease Type VII
ClinicalTrials.gov lists 5 trials for Glycogen Storage Disease Type VII or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Glycogen Storage Disease Type VII itself; the rest are tagged with a narrower condition beneath it.
When did Glycogen Storage Disease Type VII trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2018 | 2 |
| 2016 | 1 |
| 1993 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Glycogen Storage Disease Type VII trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Not applicable | 1 |
| Observational | 3 |
How many Glycogen Storage Disease Type VII trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 2 |
| Withdrawn | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Glycogen Storage Disease Type VII trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| CENTOGENE GmbH Rostock | 1 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
Which publications cover Glycogen Storage Disease Type VII? (1)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| A 5' splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease). | The Journal of biological chemistry | 1993 | Yes |
Prevalence (6)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Glycogen storage disease due to muscle phosphofructokinase deficiency | Cases families | Worldwide | Not stated | Exact | |
| Glycogen storage disease due to muscle phosphofructokinase deficiency | Cases families | Worldwide | Not stated | Exact | |
| Glycogen storage disease due to muscle phosphofructokinase deficiency | Point prevalence | <1 / 1 000 000 | Worldwide | Not stated | Exact |
| Glycogen storage disease due to muscle phosphofructokinase deficiency | Point prevalence | <1 / 1 000 000 | Worldwide | Not stated | Unspecified |
| Glycogen storage disease due to muscle phosphofructokinase deficiency | Point prevalence | <1 / 1 000 000 | Worldwide | Not stated | Exact |
Showing 5 of 6 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Glycogen storage disease due to muscle phosphofructokinase deficiency | 371 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Glycogen storage disease due to muscle phosphofructokinase deficiency | 371 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.